These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 22367369)

  • 1. Different levels of sialyl-Tn antigen expressed on MUC16 in patients with endometriosis and ovarian cancer.
    Akita K; Yoshida S; Ikehara Y; Shirakawa S; Toda M; Inoue M; Kitawaki J; Nakanishi H; Narimatsu H; Nakada H
    Int J Gynecol Cancer; 2012 May; 22(4):531-8. PubMed ID: 22367369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucins MUC16 and MUC1 are major carriers of SLe(a) and SLe(x) in borderline and malignant serous ovarian tumors.
    Ricardo S; Marcos-Silva L; Valente C; Coelho R; Gomes R; David L
    Virchows Arch; 2016 Jun; 468(6):715-22. PubMed ID: 27003157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Europium Nanoparticle-Based Sialyl-Tn Monoclonal Antibody Discriminates Epithelial Ovarian Cancer-Associated CA125 from Benign Sources.
    Gidwani K; Nadeem N; Huhtinen K; Kekki H; Heinosalo T; Hynninen J; Perheentupa A; Poutanen M; Carpen O; Pettersson K; Lamminmäki U
    J Appl Lab Med; 2019 Nov; 4(3):299-310. PubMed ID: 31659068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Basic and clinical evaluation of an immunoradiometric competitive inhibition assay for sialyl TN antigen: (2). Evaluation of clinical significance. STN Study Group].
    Imura H; Mori T; Ohkura H; Ishii M; Ariyoshi H; Endo J; Kitao M; Takeda I; Kobayashi H; Inoue M
    Gan To Kagaku Ryoho; 1989 Sep; 16(9):3221-30. PubMed ID: 2571323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbohydrate antigen expression in primary tumors, metastatic lesions, and serous effusions from patients diagnosed with epithelial ovarian carcinoma: evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions.
    Davidson B; Berner A; Nesland JM; Risberg B; Kristensen GB; Tropé CG; Bryne M
    Hum Pathol; 2000 Sep; 31(9):1081-7. PubMed ID: 11014575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of glyco-mucin profiles improves specificity of MUC16 and MUC1 biomarkers in ovarian serous tumours.
    Ricardo S; Marcos-Silva L; Pereira D; Pinto R; Almeida R; Söderberg O; Mandel U; Clausen H; Felix A; Lunet N; David L
    Mol Oncol; 2015 Feb; 9(2):503-12. PubMed ID: 25454345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of circulating serum sialyl Tn antigen levels in patients with epithelial ovarian cancer.
    Kobayashi H; Terao T; Kawashima Y
    J Clin Oncol; 1991 Jun; 9(6):983-7. PubMed ID: 1851822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of carbohydrate antigens in advanced-stage ovarian carcinomas and their metastases-A clinicopathologic study.
    Davidson B; Gotlieb WH; Ben-Baruch G; Kopolovic J; Goldberg I; Nesland JM; Berner A; Bjåmer A; Bryne M
    Gynecol Oncol; 2000 Apr; 77(1):35-43. PubMed ID: 10739688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sialyl-Tn serves as a potential therapeutic target for ovarian cancer.
    Al-Alem L; Prendergast JM; Clark J; Zarrella B; Zarrella DT; Hill SJ; Growdon WB; Pooladanda V; Spriggs DR; Cramer D; Elias KM; Nazer RI; Skates SJ; Behrens J; Dransfield DT; Rueda BR
    J Ovarian Res; 2024 Apr; 17(1):71. PubMed ID: 38566237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical significance of serum sialyl Tn antigen in patients with gynecological cancer. STN Study Group].
    Noda K; Shiota M; Tanizawa O; Inoue M; Tenjin Y; Sugishita T; Yakushiji M; Miyoshi T; Nozawa S; Sakuma T
    Gan To Kagaku Ryoho; 1991 Jul; 18(8):1287-96. PubMed ID: 2069400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the clinicopathological relevance of mesothelin level in plasma, peritoneal fluid, and tumor tissue of epithelial ovarian cancer patients.
    Okła K; Surówka J; Frąszczak K; Czerwonka A; Kaławaj K; Wawruszak A; Kotarski J; Wertel I
    Tumour Biol; 2018 Oct; 40(10):1010428318804937. PubMed ID: 30319054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tn and sialyl-Tn antigens as potential prognostic markers in human ovarian carcinoma.
    Ogawa H; Ghazizadeh M; Araki T
    Gynecol Obstet Invest; 1996; 41(4):278-83. PubMed ID: 8793500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative determination of several serum tumor markers in patients with primary epithelial ovarian carcinoma.
    Kudoh K; Kikuchi Y; Kita T; Tode T; Takano M; Hirata J; Mano Y; Yamamoto K; Nagata I
    Gynecol Obstet Invest; 1999; 47(1):52-7. PubMed ID: 9852392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum sialyl Tn as an independent predictor of poor prognosis in patients with epithelial ovarian cancer.
    Kobayashi H; Terao T; Kawashima Y
    J Clin Oncol; 1992 Jan; 10(1):95-101. PubMed ID: 1727929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of sialyl Lewis(a), sialyl Lewis(x), and sialyl Tn antigens expression levels as predictors of recurrence after curative surgery in node-negative colorectal cancer patients.
    Nakagoe T; Fukushima K; Tanaka K; Sawai T; Tsuji T; Jibiki M; Nanashima A; Yamaguchi H; Yasutake T; Ayabe H; Arisawa K
    J Exp Clin Cancer Res; 2002 Mar; 21(1):107-13. PubMed ID: 12071515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tn and Sialyl-Tn antigens in canine gastric tissues.
    Flores AR; Lemos I; Rema A; Taulescu M; Seixas F; Reis CA; Gärtner F; Amorim I
    Vet Comp Oncol; 2020 Dec; 18(4):615-625. PubMed ID: 32134186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ascites from ovarian cancer patients stimulates MUC16 mucin expression and secretion in human peritoneal mesothelial cells through an Akt-dependent pathway.
    Matte I; Garde-Granger P; Bessette P; Piché A
    BMC Cancer; 2019 Apr; 19(1):406. PubMed ID: 31039761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of ovarian cancer markers in endometriosis favours HE4 over CA125.
    Mckinnon B; Mueller MD; Nirgianakis K; Bersinger NA
    Mol Med Rep; 2015 Oct; 12(4):5179-84. PubMed ID: 26165164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Difference in mesothelin-binding ability of serum CA125 between patients with endometriosis and epithelial ovarian cancer.
    Sasaki A; Akita K; Ito F; Mori T; Kitawaki J; Nakada H
    Int J Cancer; 2015 Apr; 136(8):1985-90. PubMed ID: 25197000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant expression of MUC4 in ovarian carcinoma: diagnostic significance alone and in combination with MUC1 and MUC16 (CA125).
    Chauhan SC; Singh AP; Ruiz F; Johansson SL; Jain M; Smith LM; Moniaux N; Batra SK
    Mod Pathol; 2006 Oct; 19(10):1386-94. PubMed ID: 16880776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.